15
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human rights and the COVID-19 pandemic: a retrospective and prospective analysis

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          When the history of the COVID-19 pandemic is written, the failure of many states to live up to their human rights obligations should be a central narrative. The pandemic began with Wuhan officials in China suppressing information, silencing whistleblowers, and violating the freedom of expression and the right to health. Since then, COVID-19's effects have been profoundly unequal, both nationally and globally. These inequalities have emphatically highlighted how far countries are from meeting the supreme human rights command of non-discrimination, from achieving the highest attainable standard of health that is equally the right of all people everywhere, and from taking the human rights obligation of international assistance and cooperation seriously. We propose embedding human rights and equity within a transformed global health architecture as the necessary response to COVID-19's rights violations. This means vastly more funding from high-income countries to support low-income and middle-income countries in rights-based recoveries, plus implementing measures to ensure equitable distribution of COVID-19 medical technologies. We also emphasise structured approaches to funding and equitable distribution going forward, which includes embedding human rights into a new pandemic treaty. Above all, new legal instruments and mechanisms, from a right to health treaty to a fund for civil society right to health advocacy, are required so that the narratives of future health emergencies—and people's daily lives—are ones of equality and human rights.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          COVID-19 in Brazil: “So what?”

          The Lancet (2020)
          The coronavirus disease 2019 (COVID-19) pandemic reached Latin America later than other continents. The first case recorded in Brazil was on Feb 25, 2020. But now, Brazil has the most cases and deaths in Latin America (105 222 cases and 7288 deaths as of May 4), and these are probably substantial underestimates. Even more worryingly, the doubling of the rate of deaths is estimated at only 5 days and a recent study by Imperial College (London, UK), which analysed the active transmission rate of COVID-19 in 48 countries, showed that Brazil is the country with the highest rate of transmission (R0 of 2·81). Large cities such as São Paulo and Rio de Janeiro are the main hotspots now but there are concerns and early signs that infections are moving inland into smaller cities with inadequate provisions of intensive care beds and ventilators. Yet, perhaps the biggest threat to Brazil's COVID-19 response is its president, Jair Bolsonaro. When asked by journalists last week about the rapidly increasing numbers of COVID-19 cases, he responded: “So what? What do you want me to do?” He not only continues to sow confusion by openly flouting and discouraging the sensible measures of physical distancing and lockdown brought in by state governors and city mayors but has also lost two important and influential ministers in the past 3 weeks. First, on April 16, Luiz Henrique Mandetta, the respected and well liked Health Minister, was sacked after a television interview, in which he strongly criticised Bolsonaro's actions and called for unity, or else risk leaving the 210 million Brazilians utterly confused. Then on April 24, following the removal of the head of Brazil's federal police by Bolsonaro, Justice Minister Sérgio Moro, one of the most powerful figures of the right-wing government and appointed by Bolsonaro to combat corruption, announced his resignation. Such disarray at the heart of the administration is a deadly distraction in the middle of a public health emergency and is also a stark sign that Brazil's leadership has lost its moral compass, if it ever had one. Even without the vacuum of political actions at federal level, Brazil would have a difficult time to combat COVID-19. About 13 million Brazilians live in favelas, often with more than three people per room and little access to clean water. Physical distancing and hygiene recommendations are near impossible to follow in these environments—many favelas have organised themselves to implement measures as best as possible. Brazil has a large informal employment sector with many sources of income no longer an option. The Indigenous population has been under severe threat even before the COVID-19 outbreak because the government has been ignoring or even encouraging illegal mining and logging in the Amazon rainforest. These loggers and miners now risk bringing COVID-19 to remote populations. An open letter on May 3 by a global coalition of artists, celebrities, scientists, and intellectuals, organised by the Brazilian photojournalist Sebastião Salgado, warns of an impending genocide. What are the health and science community and civil society doing in a country known for its activism and outspoken opposition to injustice and inequity and with health as a constitutional right? Many scientific organisations, such as the Brazilian Academy of Sciences and ABRASCO, have long-opposed Bolsonaro because of severe cuts in the science budget and a more general demolition of social security and public services. In the context of COVID-19, many organisations have launched manifestos aimed at the public—such as Pact for Life and Brazil—and written statements and pleas to government officials calling for unity and joined up solutions. Pot-banging from balconies as protest during presidential announcements happens frequently. There is much research going on, from basic science to epidemiology, and there is rapid production of personal protective equipment, respirators, and testing kits. These are hopeful actions. Yet, leadership at the highest level of government is crucial in quickly averting the worst outcome of this pandemic, as is evident from other countries. In our 2009 Brazil Series, the authors concluded: “The challenge is ultimately political, requiring continuous engagement by Brazilian society as a whole to secure the right to health for all Brazilian people.” Brazil as a country must come together to give a clear answer to the “So what?” by its President. He needs to drastically change course or must be the next to go. © 2020 Bruna Prado/Getty Images 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
            • Record: found
            • Abstract: found
            • Article: not found

            Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021

            (2022)
            Background National rates of COVID-19 infection and fatality have varied dramatically since the onset of the pandemic. Understanding the conditions associated with this cross-country variation is essential to guiding investment in more effective preparedness and response for future pandemics. Methods Daily SARS-CoV-2 infections and COVID-19 deaths for 177 countries and territories and 181 subnational locations were extracted from the Institute for Health Metrics and Evaluation's modelling database. Cumulative infection rate and infection-fatality ratio (IFR) were estimated and standardised for environmental, demographic, biological, and economic factors. For infections, we included factors associated with environmental seasonality (measured as the relative risk of pneumonia), population density, gross domestic product (GDP) per capita, proportion of the population living below 100 m, and a proxy for previous exposure to other betacoronaviruses. For IFR, factors were age distribution of the population, mean body-mass index (BMI), exposure to air pollution, smoking rates, the proxy for previous exposure to other betacoronaviruses, population density, age-standardised prevalence of chronic obstructive pulmonary disease and cancer, and GDP per capita. These were standardised using indirect age standardisation and multivariate linear models. Standardised national cumulative infection rates and IFRs were tested for associations with 12 pandemic preparedness indices, seven health-care capacity indicators, and ten other demographic, social, and political conditions using linear regression. To investigate pathways by which important factors might affect infections with SARS-CoV-2, we also assessed the relationship between interpersonal and governmental trust and corruption and changes in mobility patterns and COVID-19 vaccination rates. Findings The factors that explained the most variation in cumulative rates of SARS-CoV-2 infection between Jan 1, 2020, and Sept 30, 2021, included the proportion of the population living below 100 m (5·4% [4·0–7·9] of variation), GDP per capita (4·2% [1·8–6·6] of variation), and the proportion of infections attributable to seasonality (2·1% [95% uncertainty interval 1·7–2·7] of variation). Most cross-country variation in cumulative infection rates could not be explained. The factors that explained the most variation in COVID-19 IFR over the same period were the age profile of the country (46·7% [18·4–67·6] of variation), GDP per capita (3·1% [0·3–8·6] of variation), and national mean BMI (1·1% [0·2–2·6] of variation). 44·4% (29·2–61·7) of cross-national variation in IFR could not be explained. Pandemic-preparedness indices, which aim to measure health security capacity, were not meaningfully associated with standardised infection rates or IFRs. Measures of trust in the government and interpersonal trust, as well as less government corruption, had larger, statistically significant associations with lower standardised infection rates. High levels of government and interpersonal trust, as well as less government corruption, were also associated with higher COVID-19 vaccine coverage among middle-income and high-income countries where vaccine availability was more widespread, and lower corruption was associated with greater reductions in mobility. If these modelled associations were to be causal, an increase in trust of governments such that all countries had societies that attained at least the amount of trust in government or interpersonal trust measured in Denmark, which is in the 75th percentile across these spectrums, might have reduced global infections by 12·9% (5·7–17·8) for government trust and 40·3% (24·3–51·4) for interpersonal trust. Similarly, if all countries had a national BMI equal to or less than that of the 25th percentile, our analysis suggests global standardised IFR would be reduced by 11·1%. Interpretation Efforts to improve pandemic preparedness and response for the next pandemic might benefit from greater investment in risk communication and community engagement strategies to boost the confidence that individuals have in public health guidance. Our results suggest that increasing health promotion for key modifiable risks is associated with a reduction of fatalities in such a scenario. Funding Bill & Melinda Gates Foundation, J Stanton, T Gillespie, J and E Nordstrom, and Bloomberg Philanthropies.
              • Record: found
              • Abstract: found
              • Article: not found

              An ethical framework for global vaccine allocation

              The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccine fairly and equitably

                Author and article information

                Journal
                Lancet
                Lancet
                Lancet (London, England)
                Elsevier Ltd.
                0140-6736
                1474-547X
                17 November 2022
                17 November 2022
                Affiliations
                [a ]O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Georgetown University, Washington, DC, USA
                [b ]Bangladesh Legal Aid and Services Trust, Dhaka, Bangladesh
                [c ]Partners In Health, Boston, MA, USA
                [d ]Department of Global Health and Social Medicine, Harvard Medical School, Havard University, Boston, MA, USA
                [e ]Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
                [f ]International Commission of Jurists, Geneva, Switzerland
                [g ]Clinton Foundation, New York, NY, USA
                [h ]Mailman School of Public Health, Columbia University, New York, NY, USA
                [i ]SECTION27, Johannesburg, South Africa
                [j ]The Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
                [k ]National Academy of Medicine Brazil, Rio de Janeiro, Brazil
                [l ]Champions for an AIDS-Free Generation, Nairobi, Kenya
                [m ]School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa
                [n ]South African Medical Research Council, Johannesburg, South Africa
                Author notes
                [* ]Correspondence to: Prof Lawrence O Gostin, O'Neill Institute for National and Global Health Law, Georgetown University Law Center, Georgetown University, Washington, DC, 20001, USA
                Article
                S0140-6736(22)01278-8
                10.1016/S0140-6736(22)01278-8
                9671650
                36403583
                c491d28a-12da-48a5-a611-ec9fab09b832
                © 2022 Elsevier Ltd. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Health Policy

                Medicine
                Medicine

                Comments

                Comment on this article

                Related Documents Log